1. Market Research
  2. > Healthcare Market Trends
  3. > CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Denmark

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Denmark

Summary

GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Denmark". The report is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in Denmark. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

Denmark’s population in 2013 was approximately 5.6 million, having grown at a Compound Annual Growth Rate (CAGR) of 0.5% from 2008. Denmark has a national health insurance scheme, which ensures that all of its residents have access to treatment and health services, regardless of age, income and health. In 2013, the government spent approximately $1.5 trillion on R&D and exported approximately $1.6 trillion of pharmaceutical products. The pharmaceutical market was worth $3.9 billion in 2008 and is projected to reach $3.0 billion by 2020, declining at a CAGR of 2.2%. Although the pharmaceutical market steadily increased in local currency terms between 2008 and 2013, it decreased in US dollar terms, owing to currency devaluation. The medical device market was valued at $1.3 billion in 2008 and is projected to grow at a CAGR of 4.8% to $2.3 billion in 2020, primarily attributed to -
- An increasingly elderly population
- Universal health coverage
- Government initiatives

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Denmark, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market: Takeda, Novo Nordisk, Lundbeck, Leopharma and Orifarm; and profiles and SWOT analyses of the major players in the medical device market: Siemens Healthcare, Essilor International, Johnson & Johnson Vision Care, Roche and Medtronic
- A review of the reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
- Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving Denmark’s healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to affect Denmark’s healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidation, investment, and strategic partnerships
- Identify, understand, and capitalize on the opportunities and challenges in Denmark’s healthcare market

Table Of Contents

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Denmark
1 Table of Contents

2 Introduction 19
2.1 GlobalData Report Guidance 19
3 Overview of Pharmaceutical and Medical Device Markets 20
3.1 Pharmaceutical Market 20
3.1.1 Market Overview 20
3.1.2 Pharmaceutical Exports and Imports 22
3.1.3 Supply Channels 24
3.1.4 Market Segments 25
3.1.5 Overview of Top-Five Disease Areas 28
3.1.6 Major Players 35
3.2 Medical Device Market 63
3.2.1 Market Overview 63
3.2.2 Overview of Top-Five Segments 65
3.2.3 Diagnostic Market 79
3.2.4 Major Players 81
3.3 Market Drivers and Barriers 112
3.3.1 Drivers 112
3.3.2 Barriers 113
4 Market Access 116
4.1 Reimbursement and Payer Landscape 116
4.1.1 Overview of Healthcare system 116
4.1.2 Reimbursement Process 119
4.1.3 Overview of Insurance Providers 123
4.1.4 Patient Share in Healthcare Spending 125
4.1.5 Price Trends in the Healthcare Sector 126
4.1.6 Pricing Policies 128
4.2 Regulatory Landscape 130
4.2.1 Overview of Regulatory Agencies 130
4.2.2 Market Authorization Procedure for Pharmaceutical Products 132
4.2.3 New Medical Device Approval Process 143
4.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing 148
4.2.5 Exports and Imports 149
4.2.6 Intellectual Property Rights 150
4.2.7 Clinical Trial Regulations 153
4.2.8 Pharmaceutical Advertising Regulations 155
4.2.9 Pharmacy Regulations 157
4.2.10 Labeling and Packaging Regulations 157
5 Country Analysis 161
5.1 Political Environment 161
5.1.1 Political Structure 161
5.1.2 Current Political Scenario 162
5.2 Economic Landscape 164
5.3 Economic Indicators 166
5.3.1 Gross Domestic Product 166
5.3.2 Gross National Income 170
5.3.3 Inflation 171
5.3.4 Currency Exchange Rate 174
5.3.5 Foreign Direct Investment 175
5.3.6 Foreign Exchange Reserves 176
5.3.7 Trade Balance 177
5.3.8 General Government Structural Balance 180
5.3.9 General Government Gross Debt 181
5.3.10 Major Industries. 182
5.4 Demographics 184
5.4.1 Population 184
5.4.2 Education and Literacy 201
5.4.3 Employment 203
5.4.4 Disease Burden 204
5.5 Healthcare Infrastructure 209
5.5.1 Healthcare Facilities 209
5.5.2 Healthcare Parameters 213
5.5.3 Environmental Health 215
5.5.4 Healthcare Personnel 222
5.6 Healthcare Expenditure 225
5.6.1 Overview 225
5.6.2 Share of Public and Private Sector 226
5.6.3 Pharmaceutical and Healthcare RandD Expenditure 228
5.7 Trade Associations 229
5.7.1 Danish Association of the Pharmaceutical Industry 229
5.7.2 Association of Danish Pharmacies 229
5.7.3 Danish Generic Medicines Industry Association 229
5.7.4 Danish Medical Association 229
5.8 Trade Fairs 230
6 Opportunities and Challenges 231
6.1 Opportunities 231
6.2 Challenges 232
7 Appendix 233
7.1 Abbreviation 233
7.2 Bibliography 238
7.3 Research Methodology 250
7.3.1 Coverage 250
7.3.2 Secondary Research 251
7.3.3 Forecasts 251
7.3.4 Expert Panel 251
7.4 Disclaimer 252

1.1 List of Tables

Table 1: Pharmaceutical Market, Denmark, Revenue ($bn), 2008-2013 21
Table 2: Pharmaceutical Market, Denmark, Revenue Forecast ($bn), 2014-2020 22
Table 3: Pharmaceutical Market, Denmark, Exports and Imports ($m), 2008-2013 23
Table 4: Pharmaceutical Market, Denmark, Distribution Channel Price Margin (%), 2011 25
Table 5: Pharmaceutical Market, Denmark, Over-The-Counter Drugs Market Revenue ($m), 2008-2013 28
Table 6: Pharmaceutical Market, Denmark, Antineoplastic Drug Market, Revenue ($m), 2008-2013 29
Table 7: Pharmaceutical Market, Denmark, Central Nervous System Drug Market, Revenue ($m), 2008-2013 30
Table 8: Pharmaceutical Market, Denmark, Anti-infective Drug Market, Revenue ($m), 2008-2013 32
Table 9: Pharmaceutical Market, Denmark, Respiratory Drug Market, Revenue ($m), 2008-2013 33
Table 10: Pharmaceutical Market, Denmark, Alimentary Tract Drug Market, Revenue ($m), 2008-2013 34
Table 11: Pharmaceutical Market, Takeda, Global, Major Products, 2013 36
Table 12: Pharmaceutical Market, Takeda, Global, Late-Stage Pipeline, 2014 37
Table 13: Pharmaceutical Market, Novo Nordisk, Global, Major Products, 2013 43
Table 14: Pharmaceutical Market, Novo Nordisk, Global, Late-Stage Pipeline, 2014 43
Table 15: Pharmaceutical Market, Lundbeck, Global, Major Products, 2013 49
Table 16: Pharmaceutical Market, Lundbeck, Global, Late-Stage Pipeline, 2014 50
Table 17: Medical Device Market, Denmark, Revenue ($bn), 2008-2013 63
Table 18: Medical Device Market, Denmark, Revenue Forecast ($bn), 2014-2020 64
Table 19: Medical Device Market, Denmark, Revenue by Segment, 2013 66
Table 20: Medical Device Market, Denmark, Ophthalmic Devices Market, Revenue ($m), 2008-2013 67
Table 21: Medical Device Market, Denmark, Ophthalmic Devices Market, Sales Trends for Major Players, 2012 68
Table 22: Medical Device Market, Denmark, In Vitro Diagnostic Market, Revenue ($m), 2008-2013 70
Table 23: Medical Device Market, Denmark, In Vitro Diagnostic Market, Sales Trends for Major Players, 2012 71
Table 24: Medical Device Market, Denmark, Orthopedic Market, Revenue ($m), 2008-2013 72
Table 25: Medical Device Market, Denmark, Orthopedic Market, Sales Trends for Major Players, 2012 73
Table 26: Medical Device Market, Denmark, Diagnostic Imaging Market, Revenue ($m), 2008-2013 75
Table 27: Medical Device Market, Denmark, Diagnostic Imaging Market, Sales Trends for Major Players, 2012 76
Table 28: Medical Device Market, Denmark, Healthcare IT Market, Revenue ($m), 2008-2013 78
Table 29: Medical Device Market, Denmark, Healthcare IT Market, Sales Trends for Major Players, 2012 79
Table 30: Medical Device Market, Denmark, Diagnostic Market, Revenue ($bn), 2008-2013 80
Table 31: Medical Device Market, Denmark, Diagnostic Market, Revenue Forecast ($bn), 2014-2020 81
Table 32: Medical Device Market, Denmark, Major Medical Device Companies, Revenue, 2012 82
Table 33: Medical Device Market, Roche, Global, Major Products, 2014 99
Table 34: Medical Device Market, Medtronic, Global, Major Products, 2013 106
Table 35: Market Access, Denmark, Reimbursement Threshold, 2014 123
Table 36: Market Access, Denmark, Health Insurance Coverage , 2014 125
Table 37: Healthcare Spending, Denmark, Out-Of-Pocket Expenditure (%), 2008-2013 126
Table 38: Market Access, Denmark, Consumer Price Index Annual Change (%), 2008-2013 127
Table 39: Market Authorisation, Denmark, Stages in Processing of Application, 2014 134
Table 40: Market Authorisation, Denmark, Net Assessment Time and Clock Stop Periods, 2014 135
Table 41: Market Access, Denmark, Prices and Payments for Patents, 2014 152
Table 42: Economic Indicators, Denmark, Gross Domestic Product per Capita ($), 2008-2013 167
Table 43: Economic Indicators, Denmark, Gross Domestic Product per Capita ($), 2014-2020 167
Table 44: Economic Indicators, Denmark, Gross Domestic Product Annual Growth (%), 2008-2013 168
Table 45: Economic Indicators, Denmark, Gross Domestic Product Annual Growth Forecast (%), 2014-2020 169
Table 46: Economic Indicators, Denmark, Gross National Income per Capita ($), 2008-2013 170
Table 47: Economic Indicators, Denmark, Average Consumer Price Index, 2008-2013 172
Table 48: Economic Indicators, Denmark, Average Consumer Price Index Forecast, 2014-2020 172
Table 49: Economic Indicators, Denmark, Average Consumer Price Annual Change (%), 2008-2013 173
Table 50: Economic Indicators, Denmark, Currency Exchange Rate ($/DKK), 2008-2013 174
Table 51: Economic Indicators, Denmark, Foreign Direct Investment ($bn), 2008-2013 176
Table 52: Economic Indicators, Denmark, Forex Reserves ($bn), 2008-2013 177
Table 53: Economic Indicators, Denmark, Import of Goods and Services ($bn), 2008-2013 178
Table 54: Economic Indicators, Denmark, Exports of Goods and Services ($bn), 2008-2013 179
Table 55: Economic Indicators, Denmark, General Government Structural Balance ($bn), 2008-2013 180
Table 56: Economic Indicators, Denmark, General Government Gross Debt (% of GDP), 2008-2013 182
Table 57: Economic Indicators, Denmark, Major Industries, Output ($bn), 2012-2013 183
Table 58: Demographics, Denmark, Population (million), 2008-2013 184
Table 59: Demographics, Denmark, Population Forecast (million), 2014-2020 185
Table 60: Demographics, Denmark, Population, Urban and Rural Population Share (%), 2008-2013 186
Table 61: Demographics, Denmark, Population, Urban and Rural Population Share Forecast (%), 2014-2020 187
Table 62: Demographics, Denmark, Population Distribution by Age Group (%), 2008-2013 188
Table 63: Demographics, Denmark, Population Distribution by Age Group Forecast (%), 2014-2020 189
Table 64: Demographics, Denmark, Births (per 1,000 Population), 2008-2013 190
Table 65: Demographics, Denmark, Mortality (per 1,000 Population), 2008-2013 191
Table 66: Demographics, Denmark, Major Causes of Mortality, 2012 193
Table 67: Demographics, Denmark, Mortality Rate of Children under Five (per 1,000 Live Births), 2008-2013 194
Table 68: Demographics, Denmark, Immunization Rate (%), 2008-2013 195
Table 69: Demographics, Denmark, Major Causes of Male Mortality, 2012 197
Table 70: Demographics, Denmark, Major Causes of Female Mortality, 2012 198
Table 71: Demographics, Denmark, Gender Ratio (M/F), 2008-2013 199
Table 72: Demographics, Denmark, Life Expectancy at Birth (Years), 2008-2013 201
Table 73: Demographics, Denmark, Student Enrollment by Level of Education (%), 2008-2013 202
Table 74: Demographics, Denmark, Unemployment Rate (%), 2008-2013 204
Table 75: Demographics, Denmark, Major Diseases, Male Hospitalization, 2012 206
Table 76: Demographics, Denmark, Major Diseases, Female Hospitalization, 2012 207
Table 77: Demographics, Denmark, Major Diseases, DALYs (per 100,000 Population), 2004 208
Table 78: Healthcare Infrastructure, Denmark, Hospitals, 2008-2013 210
Table 79: Healthcare Infrastructure, Denmark, Diagnostic Equipment Units (per Million Population), 2008-2013 212
Table 80: Healthcare Infrastructure, Denmark, Hospitals Beds (per 1,000 Population), 2008-2013 214
Table 81: Healthcare Infrastructure, Denmark, Physicians (per 1,000 Population), 2008-2013 215
Table 82: Healthcare Infrastructure, Denmark, CO2 Emissions (Million Metric Tons), 2008-2013 216
Table 83: Healthcare Infrastructure, Denmark, SO2 Emissions (Million Metric Tons), 2008-2013 218
Table 84: Healthcare Infrastructure, Denmark, CH4 Emissions (Million Metric Tons), 2008-2013 219
Table 85: Healthcare Infrastructure, Denmark, CO Emissions (Million Metric Tons), 2008-2013 220
Table 86: Healthcare Infrastructure, Denmark, PM10 (µg/m), 2008-2013 222
Table 87: Healthcare Infrastructure, Denmark, Nurses (per 1,000 Population), 2008-2013 223
Table 88: Healthcare Infrastructure, Denmark, Pharmacist (per 1,000 Population), 2008-2013 224
Table 89: Healthcare Infrastructure, Denmark, Dentists (per 1,000 Population), 2008-2013 225
Table 90: Healthcare Expenditure, Denmark, Healthcare Expenditure (% of GDP), 2008-2013 226
Table 91: Healthcare Expenditure, Denmark, Public-Private Share (%), 2008-2013 227
Table 92: Healthcare Expenditure, Denmark, Research and Development Expenditure ($bn), 2018-2013 229
Table 93: Healthcare Expenditure, Denmark, Major Healthcare Trade Fairs, 2014 23

1.2 List of Figures

Figure 1: Pharmaceutical Market, Denmark, Revenue ($bn), 2008-2013 21
Figure 2: Pharmaceutical Market, Denmark, Revenue Forecast ($bn), 2014-2020 22
Figure 3: Pharmaceutical Market, Denmark, Exports and Imports ($m), 2008-2013 23
Figure 4: Pharmaceutical Market, Denmark, Distribution Channels, 2012 25
Figure 5: Pharmaceutical Market, Denmark, Over-The-Counter Drugs Market Revenue ($m), 2008-2013 27
Figure 6: Pharmaceutical Market, Denmark, Antineoplastic Drug Market, Revenue ($m), 2008-2013 29
Figure 7: Pharmaceutical Market, Denmark, Central Nervous System Drug Market, Revenue ($m), 2008-2013 30
Figure 8: Pharmaceutical Market, Denmark, Anti-infective Drug Market, Revenue ($m), 2008-2013 31
Figure 9: Pharmaceutical Market, Denmark, Respiratory Drug Market, Revenue ($m), 2008-2013 33
Figure 10: Pharmaceutical Market, Denmark, Alimentary Tract Drug Market, Revenue ($m), 2008-2013 34
Figure 11: Medical Device Market, Denmark, Revenue ($bn), 2008-2013 63
Figure 12: Medical Device Market, Denmark, Revenue Forecast ($bn), 2014-2020 64
Figure 13: Medical Device Market, Denmark, Revenue by Segment ($m), 2013 65
Figure 14: Medical Device Market, Denmark, Ophthalmic Devices Market, Revenue ($m), 2008-2013 67
Figure 15: Medical Device Market, Denmark, Ophthalmic Devices Market, Sales Trends for Major Players, 2008-2012 68
Figure 16: Medical Device Market, Denmark, In Vitro Diagnostic Market, Revenue ($m), 2008-2013 69
Figure 17: Medical Device Market, Denmark, In Vitro Diagnostic Market, Sales Trends for Major Players, 2008-2012 70
Figure 18: Medical Device Market, Denmark, Orthopedic Market, Revenue ($m), 2008-2013 72
Figure 19: Medical Device Market, Denmark, Orthopedic Market, Sales Trends for Major Players, 2008-2012 73
Figure 20: Medical Device Market, Denmark, Diagnostic Imaging Market, Revenue ($m), 2008-2013 75
Figure 21: Medical Device Market, Denmark, Diagnostic Imaging Market, Sales Trends for Major Players, 2008-2012 76
Figure 22: Medical Device Market, Denmark, Healthcare IT Market, Revenue ($m), 2008-2013 77
Figure 23: Medical Device Market, Denmark, Healthcare IT Market, Sales Trends for Major Players, 2008-2012 78
Figure 24: Medical Device Market, Denmark, Diagnostic Market, Revenue ($bn), 2008-2013 80
Figure 25: Medical Device Market, Denmark, Diagnostic Market, Revenue Forecast ($bn), 2014-2020 81
Figure 26: Medical Device Market, Denmark, Major Medical Device Companies, Revenue ($m), 2012 82
Figure 27: Healthcare Market, Denmark, Drivers and Barriers, 2014 115
Figure 28: Market Access, Denmark, Healthcare System Financing, 2014 117
Figure 29: Market Access, Denmark, Healthcare System Key Players, 2014 118
Figure 30: Healthcare Spending, Denmark, Out-Of-Pocket Expenditure (%), 2008-2013 126
Figure 31: Market Access, Denmark, Consumer Price Index Annual Change (%), 2008-2013 127
Figure 32: Market Access, Denmark, Regulatory Agencies, 2014 131
Figure 33: Market Authorisation, Denmark, National Procedure , 2014 135
Figure 34: Market Authorization, Denmark, Centralized Process: Pre-submission Phase, 2014 137
Figure 35: Market Authorization, Denmark, Centralized Process: Pre-opinion Phase, 2014 139
Figure 36: Market Authorization, Denmark, Centralized Process: Post-opinion Phase, 2014 140
Figure 37: Market Authorization, Denmark, Decentralized Procedure, 2014 142
Figure 38: Market Authorization, Denmark, Mutual Recognition Procedure, 2014 143
Figure 39: Market Authorization, Denmark, Conformity Assessment of Class I Medical Devices, EU, 2014 145
Figure 40: Market Authorization, Denmark, Conformity Assessment of Class IIa Medical Devices, EU, 2014 146
Figure 41: Market Authorization, Denmark, Conformity Assessment of Class IIb Medical Devices, EU, 2014 147
Figure 42: Market Authorization, Denmark, Conformity Assessment of Class III Medical Devices, EU, 2014 148
Figure 43: Economic Indicators, Denmark, Gross Domestic Product per Capita ($), 2008-2013 166
Figure 44: Economic Indicators, Denmark, Gross Domestic Product per Capita Forecast ($), 2014-2020 167
Figure 45: Economic Indicators, Denmark, Gross Domestic Product Annual Growth (%), 2008-2013 168
Figure 46: Economic Indicators, Denmark, Gross Domestic Product Annual Growth Forecast (%), 2014-2020 169
Figure 47: Economic Indicators, Denmark, Gross National Income per Capita ($), 2008-2013 170
Figure 48: Economic Indicators, Denmark, Average Consumer Price Index, 2008-2013 171
Figure 49: Economic Indicators, Denmark, Average Consumer Price Index Forecast, 2014-2020 172
Figure 50: Economic Indicators, Denmark, Average Consumer Price Annual Change (%), 2008-2013 173
Figure 51: Economic Indicators, Denmark, Currency Exchange Rate ($/DKK), 2008-2013 174
Figure 52: Economic Indicators, Denmark, Foreign Direct Investment ($bn), 2008-2013 175
Figure 53: Economic Indicators, Denmark, Forex Reserves ($bn), 2008-2013 176
Figure 54: Economic Indicators, Denmark, Imports of Goods and Services ($bn), 2008-2013 178
Figure 55: Economic Indicators, Denmark, Exports of Goods and Services ($bn), 2008-2013 179
Figure 56: Economic Indicators, Denmark, General Government Structural Balance ($bn), 2008-2013 180
Figure 57: Economic Indicators, Denmark, General Government Gross Debt (% of GDP), 2008-2013 181
Figure 58: Economic Indicators, Denmark, Major Industries, Output ($bn), 2012-2013 183
Figure 59: Demographics, Denmark, Population (million), 2008-2013 184
Figure 60: Demographics, Denmark, Population Forecast (million), 2014-2020 185
Figure 61: Demographics, Denmark, Population, Urban and Rural Population Share (%), 2008-2013 186
Figure 62: Demographics, Denmark, Population, Urban and Rural Population Share Forecast (%), 2014-2020 187
Figure 63: Demographics, Denmark, Population Distribution by Age Group (%), 2008-2013 188
Figure 64: Demographics, Denmark, Population Distribution by Age Group Forecast (%), 2014-2020 189
Figure 65: Demographics, Denmark, Births (per 1,000 Population), 2008-2013 190
Figure 66: Demographics, Denmark, Mortality (per 1,000 Population), 2008-2013 191
Figure 67: Demographics, Denmark, Major Causes of Mortality, 2012 192
Figure 68: Demographics, Denmark, Mortality Rate of Children under Five (per 1,000 Live Births), 2008-2013 194
Figure 69: Demographics, Denmark, Immunization Rate (%), 2008-2013 195
Figure 70: Demographics, Denmark, Major Causes of Male Mortality, 2012 196
Figure 71: Demographics, Denmark, Major Causes of Female Mortality, 2012 198
Figure 72: Demographics, Denmark, Gender Ratio (M/F), 2008-2013 199
Figure 73: Demographics, Denmark, Life Expectancy at Birth (Years), 2008-2013 200
Figure 74: Demographics, Denmark, Student Enrollment by Level of Education (%), 2008-2013 202
Figure 75: Demographics, Denmark, Unemployment Rate (%), 2008-2013 204
Figure 76: Demographics, Denmark, Major Diseases, Male Hospitalization, 2012 205
Figure 77: Demographics, Denmark, Major Diseases, Female Hospitalization, 2012 206
Figure 78: Demographics, Denmark, Major Diseases, DALYs (per 100,000 Population), 2004 208
Figure 79: Healthcare Infrastructure, Denmark, Hospitals, 2008-2013 210
Figure 80: Healthcare Infrastructure, Denmark, Diagnostic Equipment Units (per Million Population), 2008-2013 212
Figure 81: Healthcare Infrastructure, Denmark, Hospitals Beds (per 1,000 Population), 2008-2013 213
Figure 82: Healthcare Infrastructure, Denmark, Physicians (per 1,000 Population), 2008-2013 214
Figure 83: Healthcare Infrastructure, Denmark, CO2 Emissions (Million Metric Tons), 2008-2013 216
Figure 84: Healthcare Infrastructure, Denmark, SO2 Emissions (Million Metric Tons), 2008-2013 218
Figure 85: Healthcare Infrastructure, Denmark, CH4 Emissions (Million Metric Tons), 2008-2013 219
Figure 86: Healthcare Infrastructure, Denmark, CO Emissions (Million Metric Tons), 2008-2013 220
Figure 87: Healthcare Infrastructure, Denmark, PM10 (µg/m), 2008-2013 221
Figure 88: Healthcare Infrastructure, Denmark, Nurses (per 1,000 Population), 2008-2013 222
Figure 89: Healthcare Infrastructure, Denmark, Pharmacist (per 1,000 Population), 2008-2013 223
Figure 90: Healthcare Infrastructure, Denmark, Dentists (per 1,000 Population), 2008-2013 224
Figure 91: Healthcare Expenditure, Denmark, Healthcare Expenditure (% of GDP), 2008-2013 226
Figure 92: Healthcare Expenditure, Denmark, Public-Private Share (%), 2008-2013 227
Figure 93: Healthcare Expenditure, Denmark, Research and Development Expenditure ($bn), 2018-2013 228
Figure 94: Healthcare Market, Denmark, Opportunities and Challenges, 2014 232

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Germany Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monitor

Germany Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monitor

  • $ 5995
  • Industry report
  • November 2016
  • by Global Data

Germany Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-El ...

Australia Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monit

Australia Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monit

  • $ 5995
  • Industry report
  • November 2016
  • by Global Data

Australia Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro- ...

India Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monitorin

India Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monitorin

  • $ 5995
  • Industry report
  • November 2016
  • by Global Data

India Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.